Eisler Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$10.2M Sell
229,700
-18,000
-7% -$841K 0.05% 215
2025
Q2
$11.5M Sell
247,700
-221,300
-47% -$10.9M 0.07% 244
2025
Q1
$28.6M Sell
469,000
-205,200
-30% -$12M 0.2% 108
2024
Q4
$38.3M Buy
+674,200
New +$37.7M 0.18% 111

Other funds holding BMY

Eisler Capital Management's BMY Position: Q3 2025 in Review

Eisler Capital Management increased its Bristol-Myers Squibb (BMY) stake by 100% in Q3 2025, buying an estimated $2.65M and bringing the position to 113,651 shares worth $5.04M. The position accounts for 0.02% of the portfolio, ranked #342.

Eisler Capital Management first reported a position in BMY in Q4 2024 and has held it in 4 quarters since. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Eisler Capital Management held 113,651 shares of Bristol-Myers Squibb worth $5.04M as of Q3 2025.
  • Eisler Capital Management bought 56,819 Bristol-Myers Squibb shares in Q3 2025, an estimated $2.65M.
  • Bristol-Myers Squibb made up 0.02% of Eisler Capital Management's portfolio in Q3 2025, its #342 holding.
  • Eisler Capital Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 4 quarters since.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.